Can network pharmacology rescue neutraceutical cancer research?

Drug Discovery Today

Volumn 17, Issue 15-16, 2012, Pages 807-809

  Azmi, Asfar S ^a   Mohammad, Ramzi M ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER PREVENTION; CANCER RESEARCH; DRUG BIOAVAILABILITY; DRUG DEVELOPMENT; HUMAN; NEOPLASM; PLEIOTROPY; REVIEW;

EID: 84864624974     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.06.008     Document Type: Editorial

References (10)

1. H. Kitano Cancer as a robust system: implications for anticancer therapy Nat. Rev. Cancer 4 2004 227 235 (Pubitemid 38337502)
2. M. Gerlinger Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2002 883 892
3. K.W. Lee Molecular targets of phytochemicals for cancer prevention Nat. Rev. Cancer 11 2011 211 218
4. R.E. Carroll Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia Cancer Prev. Res. (Phila.) 4 2011 354 364
5. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
6. E.E. Schadt A network view of disease and compound screening Nat. Rev. Drug Discov. 8 2009 286 295
7. S. Zhao, and R. Iyengar Systems pharmacology: network analysis to identify multiscale mechanisms of drug action Annu. Rev. Pharmacol. Toxicol. 52 2012 505 521
8. A.L. Barabasi Network medicine: a network-based approach to human disease Nat. Rev. Genet. 12 2011 56 68
9. A.L. Hopkins Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 4 2009 682 690
10. E.J. von PROMISCUOUS: a database for network-based drug-repositioning Nucleic Acids Res. 39 Database issue 2011 D1060 D1066